Vaccination Coverage
Global DTP3 vaccination coverage reached 85% in 2025 — close to the pre-pandemic level but still short of the 90% target that defines the WHO Immunization Agenda 2030. An estimated 13.5 million children received no routine vaccine doses in 2025, down from 14.3 million in 2024, with the largest concentrations in Nigeria, India, the DRC, Pakistan and Ethiopia.
Key insights
COVID-era backslide largely reversed
Routine immunisation services were disrupted across 2020–22; DTP3 coverage fell from 86% (2019) to 81% (2021). The recovery to 85% by 2025 closed most of the gap. Measles is the exception — declining coverage and increased mobility have driven the largest measles resurgence in a decade, with outbreaks in the US, UK, EU and across the Eastern Mediterranean region.
Zero-dose children cluster geographically
Of 14.5M zero-dose children in 2023, the year shown in the chart, more than half lived in just 10 countries. Nigeria (2.1M), India (1.6M), Ethiopia (1.1M) and the DRC (1.0M) lead. The concentration is partly conflict-driven (Yemen, Sudan, Afghanistan) and partly the result of weak primary care reaching remote and slum populations.
HPV is the slowest-rolling major vaccine
Coverage of HPV (the cervical cancer vaccine) in high-income countries averages 76% for girls aged 15. In lower-income countries it is far lower, and the global figure was 31% for a completed course in 2025. Single-dose schedules approved by WHO in 2022 cut logistics costs by half and have accelerated rollout in Bhutan, Rwanda, Kenya and Indonesia. The 90/70/90 cervical cancer elimination target requires 90% HPV coverage by age 15 globally by 2030.
Global DTP3 coverage 2000–2025
% of one-year-olds receiving 3 doses of DTP-containing vaccine
Show data table
| % DTP3 | |
|---|---|
| 2000 | 72 |
| 2005 | 79 |
| 2010 | 84 |
| 2015 | 86 |
| 2019 | 86 |
| 2020 | 83 |
| 2021 | 81 |
| 2022 | 84 |
| 2023 | 84 |
| 2024 | 85 |
| 2025 | 85 |
Key Finding: Coverage rose steadily from 72% (2000) to 86% (2019), dipped to 81% (2021) during the pandemic, and recovered to 85% by 2025.
Zero-dose children — top countries (2023)
Children receiving no routine vaccine doses, millions
Show data table
| Zero-dose (millions) | |
|---|---|
| Nigeria | 2.1 |
| India | 1.6 |
| Ethiopia | 1.1 |
| DRC | 1 |
| Pakistan | 0.8 |
| Indonesia | 0.7 |
| Yemen | 0.5 |
| Angola | 0.4 |
| Sudan | 0.4 |
| Philippines | 0.3 |
Key Finding: Just five countries account for over 40% of the global zero-dose population.
Methodology & caveats
WUENIC estimates
WHO and UNICEF produce annual estimates that reconcile administrative reports from countries with household survey data. Coverage figures are estimated, not observed — survey lags and administrative inflation in some settings mean small year-on-year movements should be read with caution.
DTP3 as a system indicator
DTP3 (the third dose of diphtheria-tetanus-pertussis-containing vaccine, typically pentavalent in most countries) is the standard proxy for the strength of a routine immunisation programme. A child receiving DTP3 by 12 months has typically had contact with primary health services three times, which proxies for system reach.
Vaccine schedule variation
Schedules vary by country. WHO recommends a core set (BCG, DTP-Hib-HepB, polio, measles, rotavirus, pneumococcal, HPV) but introduction dates differ. New vaccines (RTS,S and R21 for malaria, dengue, RSV) are being phased in through Gavi's portfolio and direct national procurement.
What the percentages hide
Coverage is measured among surviving infants, so a stable percentage in a growing birth cohort can still mean more unvaccinated children in absolute terms, which is why zero-dose counts matter. Global averages also hide steep divides: in the 2025 estimates South Asia reached 92% DTP3 while West and Central Africa stood at 71%. More than half of zero-dose children live in fragile or conflict-affected settings, where the denominators are uncertain and surveys may be impossible.
What would change the picture
The next estimates will show the effect of 2025 aid cuts on Gavi and on global measles surveillance. Measles needs about 95% two-dose coverage to stop outbreaks, and with first-dose coverage at 84% and second-dose at 77%, outbreaks will continue: 57 countries reported large or disruptive outbreaks in 2025. China's 2025 addition of HPV vaccine to its national programme could lift the global HPV figure quickly, because of its birth-cohort size.
Cite this page
GlobeChart. “Vaccination Coverage.” Last updated 2026-10-31. https://globechart.com/health/vaccination/
Please also credit the original publisher named under each chart: WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), 2026 release; WHO/UNICEF WUENIC, Gavi 5.0 strategy. Spotted an error? Tell us.